Johnson & Johnson Vision leader explains significance of latest IOL milestone

The Vision business at Johnson & Johnson MedTech has hit its latest milestone, earning a significant regulatory nod for its intraocular technology.

Last month, Johnson & Johnson announced that it received FDA approval for its Tecnis PureSee intraocular lens (IOL).

The medtech giant designed Tecnis PureSee IOL to deliver clarity of vision for patients. It says that 97% of patients report no very bothersome visual disturbances.

Read full article: https://www.massdevice.com/jj-vision-leader-iol-milestone-significance/